FDA Import Refusal SCS-3728327-7/10002/1 — ASTRAZENECA

ASTRAZENECA — FEI 3020813206

The FDA refused shipment SCS-3728327-7/10002/1 from ASTRAZENECA (India) on Sep 16, 2025. The refused product falls under Drugs and Biologics — DAPAGLIFLOZIN (ANTI-DIABETIC). Cited charges: 118,3280 This firm has 5 or more other import refusals on record.